New COVID-19 hybrid combines India and U.K. variants’ traits

The transcript discusses the detection of mutations from the UK variant in Vietnam and the spread of the Indian variant, which carries mutations L452R and E484Q. These mutations enhance the virus's ability to bind to human cells and may reduce the effectiveness of antibodies. A new variant in Vietnam combines these mutations with a Y144 deletion. Vietnam has seen a significant rise in COVID-19 cases since late April. The WHO has not assessed this new variant but has introduced a Greek alphabet-based naming system to avoid stigmatization.

What mutation allows the Indian variant of the virus to bind more stably to ACE 2 receptors?

What are the implications of the E484 Q mutation on the virus's susceptibility to antibodies?

How does the new variant found in Vietnam combine mutations from previous variants?

What has been the trend of COVID-19 infections in Vietnam since late April?

What was the WHO's stance on naming variants after specific countries?